drugset / Trial / NCT04573049
The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement
Phase 4
Unknown
124 enrolled
China National Center for Cardiovascular Diseases
China International Medical Foundation · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
A study to evaluate the effectiveness and safety of levosimendan compared with placebo in subjects with severe aortic stenosis and heart failure undergoing transcatheter aortic valve replacement
Timeline
- Start
- 2020-09-01
- Primary completion
- 2022-04-01
- Completion
- 2022-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levosimendan | Other / unclassified | 0.1 ug/kg | Other |